Medicare Enrolled

Dr. Manuel Sainz De La Pena, MD

Endocrinology · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
2727 WEST MARTIN LUTHER KING BLVD, Tampa, FL 33607
8138758453
In practice since 2006 (19 years)
NPI: 1194775817 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sainz De La Pena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sainz De La Pena? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sainz De La Pena

Dr. Manuel Sainz De La Pena is an endocrinology in Tampa, FL, with 19 years in practice. Based on federal Medicare data, Dr. Sainz De La Pena performed 2,847 Medicare services across 845 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sainz De La Pena received a total of $293,308 from 72 pharmaceutical and/or device companies across 1178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sainz De La Pena is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 22% volume in FL$ $293,308 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,847
Medicare services
Top 22% in FL for endocrinology
845
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~150 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)1,620$18$47
Office visit, established patient (30-39 min)569$90$273
Hospital follow-up visit, moderate complexity194$62$186
Office visit, established patient, complex (40-54 min)104$134$366
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report88$26$91
Initial hospital admission, moderate complexity77$101$350
New patient office visit (45-59 min)71$117$415
Sleep study including heart rate, breathing, and sleep time36$83$417
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle27$52$195
Hemoglobin A1c test (diabetes monitoring)25$10$27
New patient office visit, complex (60-74 min)19$173$523
Blood glucose (sugar) test performed by hand-held instrument17$3$8
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$293,308
Total received (2018-2024)
Avg $41,901/year across 7 years
Top 4% in FL for endocrinology
72
Companies
1,178
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$271,548 (92.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,552 (5.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,209 (2.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,174
2023
$43,773
2022
$61,178
2021
$20,330
2020
$16,118
2019
$47,579
2018
$91,156

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$229,801
Boehringer Ingelheim Pharmaceuticals, Inc.
$18,238
Bayer Healthcare Pharmaceuticals Inc.
$11,171
Bayer HealthCare Pharmaceuticals Inc.
$9,923
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$6,520
SANOFI-AVENTIS U.S. LLC
$4,107
Lilly USA, LLC
$1,763
Amgen Inc.
$953
Corcept Therapeutics
$952
Amarin Pharma Inc.
$766
Abbott Laboratories
$634
Senseonics, Incorporated
$632
AstraZeneca Pharmaceuticals LP
$626
Dexcom, Inc.
$511
Horizon Therapeutics plc
$429
RECORDATI_RARE_DISEASES_INC.
$398
Esperion Therapeutics, Inc.
$364
Tandem Diabetes Care, Inc.
$340
Xeris Pharmaceuticals, Inc.
$273
Mannkind Corporation
$269
Radius Health, Inc.
$253
Janssen Pharmaceuticals, Inc
$249
Insulet Corporation
$224
Amryt Pharma Holdings Ltd
$220
Nevro Corp.
$209
Shire North American Group Inc
$205
Amneal Pharmaceuticals LLC
$193
MannKind Corporation
$192
Kyowa Kirin, Inc.
$190
AbbVie Inc.
$181
AbbVie, Inc.
$181
IBSA Pharma Inc.
$170
DEXCOM, INC.
$133
Astellas Pharma US Inc
$126
CeQur Corporation
$122
Merck Sharp & Dohme Corporation
$119
Alexion Pharmaceuticals, Inc.
$119
ABBVIE INC.
$111
Companion Medical, Inc.
$100
United Therapeutics Corporation
$100
EUSA Pharma (US) LLC
$89
Valeritas, Inc.
$76
Medtronic, Inc.
$71
OPKO Pharmaceuticals, LLC
$70
Antares Pharma, Inc.
$69
Ascensia Diabetes Care Us Inc.
$68
PFIZER INC.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$52
Merck Sharp & Dohme LLC
$51
Novartis Pharmaceuticals Corporation
$51
BETA BIONICS, INC.
$51
LifeScan, Inc.
$47
Zealand Pharma US, Inc.
$44
Kowa Pharmaceuticals America, Inc.
$35
Avvisto Therapeutics, LLC
$34
Medtronic MiniMed, Inc.
$33
Rhythm Pharmaceuticals, Inc.
$33
Acerus Pharmaceuticals Corporation
$32
LIFESCAN, INC.
$29
ARBOR PHARMACEUTICALS, INC.
$24
Madrigal Pharmaceuticals
$23
Ipsen Biopharmaceuticals, Inc
$23
Hikma Pharmaceuticals USA
$22
Renalytix AI, Inc.
$22
West-Ward Pharmaceuticals
$20
Ultragenyx Pharmaceutical Inc.
$19
Synergy Pharmaceuticals Inc
$19
GlaxoSmithKline, LLC.
$16
Teva Pharmaceuticals USA, Inc.
$14
VistaPharm, Inc.
$14
Medtronic USA, Inc.
$12
Orexigen Therapeutics, Inc.
$11
Top 3 companies account for 88.4% of total payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · Aimovig · Amitiza · BAQSIMI · BASAGLAR · BELSOMRA · CONTRAVE · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · Edarbi · Edarbyclor · Eversense · FARXIGA · FASENRA · FIASP · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INTELLIS · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Livalo · MINIMED 780G · MOUNJARO · MULTAQ · MYCAPSSA · Minimed 670G System · Mitigare · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · Natesto · OT Verio Flex Starter Kit · Omnia · Omnipod · OneTouch · Otezla · Ozempic · PREVNAR - 13 · Prolia · RAYOS · RECORLEV · RESMETIROM · RYBELSUS · Rayaldee · Rayaldee (old) · Repatha · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · SPIRIVA RESPIMAT · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Senza · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TYVASO · TZIELD · Thyquidity · Tirosint · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · UNITHROID · Uloric · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VESICARE · Vascepa · Victoza · WINREVAIR · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for endocrinology in FL.

Equivalent to $10,302 per 100 Medicare services performed
Looking for a endocrinology in Tampa?
Compare endocrinologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
75
Per 100K population
5.0
County median income
$75,011
Nearest hospital
ST JOSEPHS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sainz De La Pena is a clinical cardiology specialist, with above-average Medicare volume (top 22% in FL), and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sainz De La Pena experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sainz De La Pena performed 1,620 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sainz De La Pena receive payments from pharmaceutical companies?
Yes. Dr. Sainz De La Pena received a total of $293,308 from 72 companies across 1,178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sainz De La Pena's costs compare to other endocrinologys in Tampa?
Dr. Sainz De La Pena's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sainz De La Pena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →